FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 1491024 · Received July 31, 2009

Report

Report Number
2027969-2009-00617
Event Type
Malfunction
Date Received
July 31, 2009
Date of Event
July 7, 2009
Report Date
July 30, 2009
Manufacturer
BIOSITE INCORPORATED
Product Code
JPA
PMA / PMN Number
021923
Removal / Correction Number
NI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

DISCREPANT RESULTS (ACCURACY) COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED. DATE: (B)(6) 2009, INRATIO: 4.1, LAB: 3.3, MEAN: 3.70, CONFIDENCE LIMITS: 2.2-5.3. THE MEAN OF THE INRATIO METER AND COMPARATIVE SYSTEM INR WERE CALCULATED. BOTH INRATIO AND LAB VALUES ARE WITHIN THE CONFIDENCE LIMITS FOR INR TESTING. THE RESULTS ARE NOT CONSIDERED DISCREPANT WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. FUNCTIONAL TESTING IS NOT REQUIRED AT THIS TIME; METER AND STRIPS ARE NOT EXPECTED TO BE RETURNED. THIS FAILURE MODE WILL CONTINUE TO BE MONITORED TO DETERMINE IF FUTURE CORRECTIVE ACTION IS WARRANTED. AS OF 07/15/2009, 25 DISCREPANT RESULTS COMPLAINTS WERE REPORTED FOR LOT #080868 YIELDING A COMPLAINT RATE OF 0.008%. DUE TO THIS LOW OCCURRENCE RATE, BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION (>0.07%) NO FURTHER ACTION IS REQUIRED AT THIS TIME. ON GOING TRENDING SHALL BE PERFORMED TO DETERMINE IF FURTHER ACTION IS WARRANTED. NO CORRECTIVE ACTION REQUIRED AT THIS TIME AS NO PRODUCT DEFICIENCY WAS ESTABLISHED.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOWS:" DATE: (B)(6) 2009, INRATIO: 4.1, LAB: 3.3.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST JPA BIOSITE INCORPORATED 0100007 080868

Patients

Seq Age Sex Outcome Treatment
1 NI